ALS Town Hall

Your support fuels our research to #EndALS! Donate Now

ALS Town Hall

The ALS Town Hall is a virtual discussion led by experts in the fields of research, patient advocacy, care, awareness building, and fundraising.

Hosted by the ALS Therapy Development Institute (ALS TDI), each event begins with brief presentations from guest speakers and then invites the community to ask questions and engage in live discussion.

See upcoming events below and click the register button to sign up.

ALS Town Hall

The ALS Town Hall is a virtual discussion led by experts in the fields of research, patient advocacy, care, awareness building, and fundraising.

See upcoming events below and click the register button to sign up.

How to Participate

When you register, you'll receive an email with instructions, including a link to join via video and/or dial-in options to use at the time of the event. Please note, attendees are not required to use video when participating in town hall.

Upcoming ALS Town Halls

ALS Town Hall: Discussion on Tegoprubart Phase 2a Results

Led by Dr. David-Alexandre C. Gros and Dr. Steve Perrin of Eledon Pharmaceuticals

Wednesday, July 27, 2022 | 3:00 - 4:00pm EDT

On Wednesday, July 27, 2022, ALS TDI will be hosting a new ALS Town Hall discussion on tegoprubart. Tegoprubart is a potential treatment for ALS that was invented at ALS TDI and recently completed a phase 2a trial carried out by Eledon Pharmaceuticals. The discussion will be led by Eledon's Chief Executive Officer, Dr. David-Alexandre C. Gros, and President and Chief Scientific Officer, Dr. Steve Perrin, who will provide an overview of the drug mechanisms and the trial results.